公开(公告)号：US20240366832A1

公开(公告)日：2024-11-07

申请号：US18654634

申请日：2024-05-03

Applicant: Boston Scientific Scimed, Inc.

Inventor： Siavash Sam PARKHIDEH ,  Nicolas BALL-JONES ,  Scott Edward CORBEIL ,  Joseph Thomas DELANEY, Jr. ,  Allison KUMARASENA ,  Lauren Sfakis LYDECKER ,  Cristian PARISI ,  Peijiang WANG ,  Dawn WINSOR-HINES

IPC: A61L27/18

Abstract: Compositions useful in medical procedures are described, such as separating tissue layers, e.g., submucosal tissue layers, for removal. In some examples, the compositions may include a pharmaceutically acceptable carrier fluid and one or more biocompatible materials at least partially or completely dissolved or suspended in the pharmaceutically acceptable carrier fluid. The one or more biocompatible materials may be chosen from polymers, phospholipids, nanoclays, or combinations thereof. Advantageously, the compositions may be formulated as a solution, emulsion, gel, or suspension capable of being injected into tissue.

公开(公告)号：US20180110979A1

公开(公告)日：2018-04-26

申请号：US15789025

申请日：2017-10-20

Applicant: Boston Scientific Scimed, Inc. ,  Lifespan Corporation

Inventor： Jeri Ann HILLER ,  John Allen HINGSTON ,  Ding Sheng HE ,  Dawn WINSOR-HINES ,  Harlan RICH ,  Kathleen CORCORAN ,  Gary Dean ROYE ,  Beth RYDER ,  Sivamainthan VITHIANANTHAN ,  Peter J. SNYDER ,  Gene Thomas STORBECK ,  Kali MANNING ,  Selina M. MERKLING ,  Holly Elizabeth ROCKWEILER

IPC: A61N1/36 ,  A61B5/00 ,  A61N1/378 ,  A61B18/14

CPC classification number: A61N1/36007 ,  A61B5/0245 ,  A61B5/04884 ,  A61B5/4227 ,  A61B5/4238 ,  A61B5/4255 ,  A61B5/4283 ,  A61B5/4869 ,  A61B5/6843 ,  A61B5/6844 ,  A61B5/6852 ,  A61B5/6871 ,  A61B5/6873 ,  A61B18/1477 ,  A61B18/1492 ,  A61B2018/00023 ,  A61B2018/0022 ,  A61B2018/00267 ,  A61B2018/00494 ,  A61B2018/00577 ,  A61B2018/00839 ,  A61B2090/065 ,  A61N1/378

Abstract: A system for treating a gastrointestinal tract may include a device configured to measure electrical activity at a plurality of locations within a gastrointestinal tract of a patient, a controller configured to compare the measured activity from the plurality of locations to a database of electrical activity corresponding to one or more gastric events, abnormalities, or dysrhythmias. The controller may be configured to determine one or more treatment locations based on the comparison, and cause the device to deliver therapy to the one or more treatment locations.